NCT01387295 2023-12-11
Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease
Herlev Hospital
Phase 2 Completed
Clinical Trials
12 trialsNCT00297596 2021-10-28
Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT01387373 2020-10-05
Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer
Herlev Hospital
Phase 2 Completed
NCT00216021 2015-12-09
Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer
Hoosier Cancer Research Network
Phase 2 Completed
NCT01658033 2015-09-09
Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients
Fudan University
Phase 2 Completed
NCT00159458 2014-05-22
Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer
University of Southern California
Phase 2 Terminated
NCT00527930 2013-10-10
TORCH
Seoul National University Hospital
Phase 2 Completed
NCT00006121 2012-07-24
Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT01528826 2012-02-08
NVBOX
Fudan University
Phase 2 Unknown
NCT01351597 2011-05-11
STORM
Korean Breast Cancer Study Group
Phase 2 Unknown
NCT00216073 2011-05-02
Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer
Hoosier Cancer Research Network
Phase 2 Terminated
NCT00403988 2008-11-04
Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (HerceptinĀ®) in Advanced Breast Carcinoma
American University of Beirut Medical Center
Phase 2 Terminated